ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Vaccines for the Elderly Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-38M17731
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Vaccines for the Elderly Market Research Report 2024
BUY CHAPTERS

Global Vaccines for the Elderly Market Research Report 2025

Code: QYRE-Auto-38M17731
Report
June 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
CSL Limited
Hualan Bio
Sinovac
Kangtai Bio
CDIBP
Walvax

Vaccines for the Elderly Market

The global market for Vaccines for the Elderly was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Vaccines for the Elderly is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Vaccines for the Elderly is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Vaccines for the Elderly include Pfizer, GSK, Merck, CSL, Sanofi, AstraZeneca, Hualan Bio, Sinovac, Kangtai Bio, CDIBP, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Vaccines for the Elderly, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccines for the Elderly.
The Vaccines for the Elderly market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vaccines for the Elderly market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccines for the Elderly manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Vaccines for the Elderly Market Report

Report Metric Details
Report Name Vaccines for the Elderly Market
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Public Health Agency
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, GSK, Merck, CSL, Sanofi, AstraZeneca, Hualan Bio, Sinovac, Kangtai Bio, CDIBP, Walvax
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Vaccines for the Elderly manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Vaccines for the Elderly in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Vaccines for the Elderly Market report?

Ans: The main players in the Vaccines for the Elderly Market are Pfizer, GSK, Merck, CSL, Sanofi, AstraZeneca, Hualan Bio, Sinovac, Kangtai Bio, CDIBP, Walvax

What are the Application segmentation covered in the Vaccines for the Elderly Market report?

Ans: The Applications covered in the Vaccines for the Elderly Market report are Hospital, Clinic, Public Health Agency, Others

What are the Type segmentation covered in the Vaccines for the Elderly Market report?

Ans: The Types covered in the Vaccines for the Elderly Market report are Flu Vaccine, Respiratory Syncytial Virus (RSV) Vaccine, Recombinant Herpes Zoster Vaccine, 23-Valent Pneumococcal Polysaccharide Vaccine, Others

Recommended Reports

Disease Specific Vaccines

Vaccine Adjuvants & Devices

Preventive & Therapeutic Vaccines

1 Vaccines for the Elderly Market Overview
1.1 Product Definition
1.2 Vaccines for the Elderly by Type
1.2.1 Global Vaccines for the Elderly Market Value Comparison by Type (2024 VS 2031)
1.2.2 Flu Vaccine
1.2.3 Respiratory Syncytial Virus (RSV) Vaccine
1.2.4 Recombinant Herpes Zoster Vaccine
1.2.5 23-Valent Pneumococcal Polysaccharide Vaccine
1.2.6 Others
1.3 Vaccines for the Elderly by Application
1.3.1 Global Vaccines for the Elderly Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Public Health Agency
1.3.5 Others
1.4 Global Vaccines for the Elderly Market Size Estimates and Forecasts
1.4.1 Global Vaccines for the Elderly Revenue 2020-2031
1.4.2 Global Vaccines for the Elderly Sales 2020-2031
1.4.3 Global Vaccines for the Elderly Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Vaccines for the Elderly Market Competition by Manufacturers
2.1 Global Vaccines for the Elderly Sales Market Share by Manufacturers (2020-2025)
2.2 Global Vaccines for the Elderly Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Vaccines for the Elderly Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Vaccines for the Elderly, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vaccines for the Elderly, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vaccines for the Elderly, Product Type & Application
2.7 Global Key Manufacturers of Vaccines for the Elderly, Date of Enter into This Industry
2.8 Global Vaccines for the Elderly Market Competitive Situation and Trends
2.8.1 Global Vaccines for the Elderly Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Vaccines for the Elderly Players Market Share by Revenue
2.8.3 Global Vaccines for the Elderly Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Vaccines for the Elderly Market Scenario by Region
3.1 Global Vaccines for the Elderly Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Vaccines for the Elderly Sales by Region: 2020-2031
3.2.1 Global Vaccines for the Elderly Sales by Region: 2020-2025
3.2.2 Global Vaccines for the Elderly Sales by Region: 2026-2031
3.3 Global Vaccines for the Elderly Revenue by Region: 2020-2031
3.3.1 Global Vaccines for the Elderly Revenue by Region: 2020-2025
3.3.2 Global Vaccines for the Elderly Revenue by Region: 2026-2031
3.4 North America Vaccines for the Elderly Market Facts & Figures by Country
3.4.1 North America Vaccines for the Elderly Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Vaccines for the Elderly Sales by Country (2020-2031)
3.4.3 North America Vaccines for the Elderly Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Vaccines for the Elderly Market Facts & Figures by Country
3.5.1 Europe Vaccines for the Elderly Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Vaccines for the Elderly Sales by Country (2020-2031)
3.5.3 Europe Vaccines for the Elderly Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vaccines for the Elderly Market Facts & Figures by Region
3.6.1 Asia Pacific Vaccines for the Elderly Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Vaccines for the Elderly Sales by Region (2020-2031)
3.6.3 Asia Pacific Vaccines for the Elderly Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Vaccines for the Elderly Market Facts & Figures by Country
3.7.1 Latin America Vaccines for the Elderly Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Vaccines for the Elderly Sales by Country (2020-2031)
3.7.3 Latin America Vaccines for the Elderly Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vaccines for the Elderly Market Facts & Figures by Country
3.8.1 Middle East and Africa Vaccines for the Elderly Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Vaccines for the Elderly Sales by Country (2020-2031)
3.8.3 Middle East and Africa Vaccines for the Elderly Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vaccines for the Elderly Sales by Type (2020-2031)
4.1.1 Global Vaccines for the Elderly Sales by Type (2020-2025)
4.1.2 Global Vaccines for the Elderly Sales by Type (2026-2031)
4.1.3 Global Vaccines for the Elderly Sales Market Share by Type (2020-2031)
4.2 Global Vaccines for the Elderly Revenue by Type (2020-2031)
4.2.1 Global Vaccines for the Elderly Revenue by Type (2020-2025)
4.2.2 Global Vaccines for the Elderly Revenue by Type (2026-2031)
4.2.3 Global Vaccines for the Elderly Revenue Market Share by Type (2020-2031)
4.3 Global Vaccines for the Elderly Price by Type (2020-2031)
5 Segment by Application
5.1 Global Vaccines for the Elderly Sales by Application (2020-2031)
5.1.1 Global Vaccines for the Elderly Sales by Application (2020-2025)
5.1.2 Global Vaccines for the Elderly Sales by Application (2026-2031)
5.1.3 Global Vaccines for the Elderly Sales Market Share by Application (2020-2031)
5.2 Global Vaccines for the Elderly Revenue by Application (2020-2031)
5.2.1 Global Vaccines for the Elderly Revenue by Application (2020-2025)
5.2.2 Global Vaccines for the Elderly Revenue by Application (2026-2031)
5.2.3 Global Vaccines for the Elderly Revenue Market Share by Application (2020-2031)
5.3 Global Vaccines for the Elderly Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Vaccines for the Elderly Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Vaccines for the Elderly Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Vaccines for the Elderly Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK Vaccines for the Elderly Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Vaccines for the Elderly Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Vaccines for the Elderly Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 CSL
6.4.1 CSL Company Information
6.4.2 CSL Description and Business Overview
6.4.3 CSL Vaccines for the Elderly Sales, Revenue and Gross Margin (2020-2025)
6.4.4 CSL Vaccines for the Elderly Product Portfolio
6.4.5 CSL Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Company Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Vaccines for the Elderly Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sanofi Vaccines for the Elderly Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 AstraZeneca
6.6.1 AstraZeneca Company Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Vaccines for the Elderly Sales, Revenue and Gross Margin (2020-2025)
6.6.4 AstraZeneca Vaccines for the Elderly Product Portfolio
6.6.5 AstraZeneca Recent Developments/Updates
6.7 Hualan Bio
6.7.1 Hualan Bio Company Information
6.7.2 Hualan Bio Description and Business Overview
6.7.3 Hualan Bio Vaccines for the Elderly Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hualan Bio Vaccines for the Elderly Product Portfolio
6.7.5 Hualan Bio Recent Developments/Updates
6.8 Sinovac
6.8.1 Sinovac Company Information
6.8.2 Sinovac Description and Business Overview
6.8.3 Sinovac Vaccines for the Elderly Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sinovac Vaccines for the Elderly Product Portfolio
6.8.5 Sinovac Recent Developments/Updates
6.9 Kangtai Bio
6.9.1 Kangtai Bio Company Information
6.9.2 Kangtai Bio Description and Business Overview
6.9.3 Kangtai Bio Vaccines for the Elderly Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Kangtai Bio Vaccines for the Elderly Product Portfolio
6.9.5 Kangtai Bio Recent Developments/Updates
6.10 CDIBP
6.10.1 CDIBP Company Information
6.10.2 CDIBP Description and Business Overview
6.10.3 CDIBP Vaccines for the Elderly Sales, Revenue and Gross Margin (2020-2025)
6.10.4 CDIBP Vaccines for the Elderly Product Portfolio
6.10.5 CDIBP Recent Developments/Updates
6.11 Walvax
6.11.1 Walvax Company Information
6.11.2 Walvax Description and Business Overview
6.11.3 Walvax Vaccines for the Elderly Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Walvax Vaccines for the Elderly Product Portfolio
6.11.5 Walvax Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vaccines for the Elderly Industry Chain Analysis
7.2 Vaccines for the Elderly Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vaccines for the Elderly Production Mode & Process Analysis
7.4 Vaccines for the Elderly Sales and Marketing
7.4.1 Vaccines for the Elderly Sales Channels
7.4.2 Vaccines for the Elderly Distributors
7.5 Vaccines for the Elderly Customer Analysis
8 Vaccines for the Elderly Market Dynamics
8.1 Vaccines for the Elderly Industry Trends
8.2 Vaccines for the Elderly Market Drivers
8.3 Vaccines for the Elderly Market Challenges
8.4 Vaccines for the Elderly Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck
CSL Limited
Hualan Bio
Sinovac
Kangtai Bio
CDIBP
Walvax
List of Tables
 Table 1. Global Vaccines for the Elderly Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Vaccines for the Elderly Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Vaccines for the Elderly Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Vaccines for the Elderly Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Vaccines for the Elderly Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Vaccines for the Elderly Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Vaccines for the Elderly Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Vaccines for the Elderly Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Vaccines for the Elderly, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Vaccines for the Elderly, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Vaccines for the Elderly, Product Type & Application
 Table 12. Global Key Manufacturers of Vaccines for the Elderly, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Vaccines for the Elderly by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccines for the Elderly as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Vaccines for the Elderly Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Vaccines for the Elderly Sales by Region (2020-2025) & (K Units)
 Table 18. Global Vaccines for the Elderly Sales Market Share by Region (2020-2025)
 Table 19. Global Vaccines for the Elderly Sales by Region (2026-2031) & (K Units)
 Table 20. Global Vaccines for the Elderly Sales Market Share by Region (2026-2031)
 Table 21. Global Vaccines for the Elderly Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Vaccines for the Elderly Revenue Market Share by Region (2020-2025)
 Table 23. Global Vaccines for the Elderly Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Vaccines for the Elderly Revenue Market Share by Region (2026-2031)
 Table 25. North America Vaccines for the Elderly Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Vaccines for the Elderly Sales by Country (2020-2025) & (K Units)
 Table 27. North America Vaccines for the Elderly Sales by Country (2026-2031) & (K Units)
 Table 28. North America Vaccines for the Elderly Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Vaccines for the Elderly Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Vaccines for the Elderly Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Vaccines for the Elderly Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Vaccines for the Elderly Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Vaccines for the Elderly Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Vaccines for the Elderly Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Vaccines for the Elderly Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Vaccines for the Elderly Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Vaccines for the Elderly Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Vaccines for the Elderly Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Vaccines for the Elderly Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Vaccines for the Elderly Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Vaccines for the Elderly Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Vaccines for the Elderly Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Vaccines for the Elderly Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Vaccines for the Elderly Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Vaccines for the Elderly Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Vaccines for the Elderly Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Vaccines for the Elderly Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Vaccines for the Elderly Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Vaccines for the Elderly Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Vaccines for the Elderly Sales (K Units) by Type (2020-2025)
 Table 51. Global Vaccines for the Elderly Sales (K Units) by Type (2026-2031)
 Table 52. Global Vaccines for the Elderly Sales Market Share by Type (2020-2025)
 Table 53. Global Vaccines for the Elderly Sales Market Share by Type (2026-2031)
 Table 54. Global Vaccines for the Elderly Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Vaccines for the Elderly Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Vaccines for the Elderly Revenue Market Share by Type (2020-2025)
 Table 57. Global Vaccines for the Elderly Revenue Market Share by Type (2026-2031)
 Table 58. Global Vaccines for the Elderly Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Vaccines for the Elderly Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Vaccines for the Elderly Sales (K Units) by Application (2020-2025)
 Table 61. Global Vaccines for the Elderly Sales (K Units) by Application (2026-2031)
 Table 62. Global Vaccines for the Elderly Sales Market Share by Application (2020-2025)
 Table 63. Global Vaccines for the Elderly Sales Market Share by Application (2026-2031)
 Table 64. Global Vaccines for the Elderly Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Vaccines for the Elderly Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Vaccines for the Elderly Revenue Market Share by Application (2020-2025)
 Table 67. Global Vaccines for the Elderly Revenue Market Share by Application (2026-2031)
 Table 68. Global Vaccines for the Elderly Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Vaccines for the Elderly Price (US$/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Vaccines for the Elderly Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Vaccines for the Elderly Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. GSK Company Information
 Table 76. GSK Description and Business Overview
 Table 77. GSK Vaccines for the Elderly Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. GSK Vaccines for the Elderly Product
 Table 79. GSK Recent Developments/Updates
 Table 80. Merck Company Information
 Table 81. Merck Description and Business Overview
 Table 82. Merck Vaccines for the Elderly Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Merck Vaccines for the Elderly Product
 Table 84. Merck Recent Developments/Updates
 Table 85. CSL Company Information
 Table 86. CSL Description and Business Overview
 Table 87. CSL Vaccines for the Elderly Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. CSL Vaccines for the Elderly Product
 Table 89. CSL Recent Developments/Updates
 Table 90. Sanofi Company Information
 Table 91. Sanofi Description and Business Overview
 Table 92. Sanofi Vaccines for the Elderly Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Sanofi Vaccines for the Elderly Product
 Table 94. Sanofi Recent Developments/Updates
 Table 95. AstraZeneca Company Information
 Table 96. AstraZeneca Description and Business Overview
 Table 97. AstraZeneca Vaccines for the Elderly Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. AstraZeneca Vaccines for the Elderly Product
 Table 99. AstraZeneca Recent Developments/Updates
 Table 100. Hualan Bio Company Information
 Table 101. Hualan Bio Description and Business Overview
 Table 102. Hualan Bio Vaccines for the Elderly Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Hualan Bio Vaccines for the Elderly Product
 Table 104. Hualan Bio Recent Developments/Updates
 Table 105. Sinovac Company Information
 Table 106. Sinovac Description and Business Overview
 Table 107. Sinovac Vaccines for the Elderly Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Sinovac Vaccines for the Elderly Product
 Table 109. Sinovac Recent Developments/Updates
 Table 110. Kangtai Bio Company Information
 Table 111. Kangtai Bio Description and Business Overview
 Table 112. Kangtai Bio Vaccines for the Elderly Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Kangtai Bio Vaccines for the Elderly Product
 Table 114. Kangtai Bio Recent Developments/Updates
 Table 115. CDIBP Company Information
 Table 116. CDIBP Description and Business Overview
 Table 117. CDIBP Vaccines for the Elderly Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. CDIBP Vaccines for the Elderly Product
 Table 119. CDIBP Recent Developments/Updates
 Table 120. Walvax Company Information
 Table 121. Walvax Description and Business Overview
 Table 122. Walvax Vaccines for the Elderly Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Walvax Vaccines for the Elderly Product
 Table 124. Walvax Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Vaccines for the Elderly Distributors List
 Table 128. Vaccines for the Elderly Customers List
 Table 129. Vaccines for the Elderly Market Trends
 Table 130. Vaccines for the Elderly Market Drivers
 Table 131. Vaccines for the Elderly Market Challenges
 Table 132. Vaccines for the Elderly Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Vaccines for the Elderly
 Figure 2. Global Vaccines for the Elderly Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Vaccines for the Elderly Market Share by Type: 2024 & 2031
 Figure 4. Flu Vaccine Product Picture
 Figure 5. Respiratory Syncytial Virus (RSV) Vaccine Product Picture
 Figure 6. Recombinant Herpes Zoster Vaccine Product Picture
 Figure 7. 23-Valent Pneumococcal Polysaccharide Vaccine Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Vaccines for the Elderly Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Vaccines for the Elderly Market Share by Application: 2024 & 2031
 Figure 11. Hospital
 Figure 12. Clinic
 Figure 13. Public Health Agency
 Figure 14. Others
 Figure 15. Global Vaccines for the Elderly Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Vaccines for the Elderly Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Vaccines for the Elderly Sales (2020-2031) & (K Units)
 Figure 18. Global Vaccines for the Elderly Average Price (US$/Unit) & (2020-2031)
 Figure 19. Vaccines for the Elderly Report Years Considered
 Figure 20. Vaccines for the Elderly Sales Share by Manufacturers in 2024
 Figure 21. Global Vaccines for the Elderly Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Vaccines for the Elderly Players: Market Share by Revenue in Vaccines for the Elderly in 2024
 Figure 23. Vaccines for the Elderly Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Vaccines for the Elderly Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Vaccines for the Elderly Sales Market Share by Country (2020-2031)
 Figure 26. North America Vaccines for the Elderly Revenue Market Share by Country (2020-2031)
 Figure 27. United States Vaccines for the Elderly Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Vaccines for the Elderly Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Vaccines for the Elderly Sales Market Share by Country (2020-2031)
 Figure 30. Europe Vaccines for the Elderly Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Vaccines for the Elderly Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Vaccines for the Elderly Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Vaccines for the Elderly Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Vaccines for the Elderly Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Vaccines for the Elderly Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Vaccines for the Elderly Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Vaccines for the Elderly Revenue Market Share by Region (2020-2031)
 Figure 38. China Vaccines for the Elderly Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Vaccines for the Elderly Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Vaccines for the Elderly Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Vaccines for the Elderly Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Vaccines for the Elderly Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. China Taiwan Vaccines for the Elderly Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Southeast Asia Vaccines for the Elderly Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Vaccines for the Elderly Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Vaccines for the Elderly Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Vaccines for the Elderly Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Vaccines for the Elderly Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Vaccines for the Elderly Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Vaccines for the Elderly Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Vaccines for the Elderly Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Vaccines for the Elderly Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Vaccines for the Elderly Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Vaccines for the Elderly Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Vaccines for the Elderly by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Vaccines for the Elderly by Type (2020-2031)
 Figure 57. Global Vaccines for the Elderly Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Vaccines for the Elderly by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Vaccines for the Elderly by Application (2020-2031)
 Figure 60. Global Vaccines for the Elderly Price (US$/Unit) by Application (2020-2031)
 Figure 61. Vaccines for the Elderly Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Adult Vaccines Market Research Report 2024
Global Respiratory Syncytial Virus Vaccine for the Elderly Market Research Report 2024
Global Seasonal Vaccines Market Research Report 2024
Global Adult and Pediatric Vaccines Market Research Report 2024
Global Multiple Vaccine Market Research Report 2024
Global Vaccines For Cattle And Sheep Market Research Report 2024
Global HIV and AIDS Vaccine Market Research Report 2024
Global Norovirus Vaccine Market Research Report 2024
Global Elderly Hearing Aids Market Research Report 2025
Global HIV Vaccine Market Research Report 2025
Global Inactivated Poultry Vaccines Market Research Report 2024
Global Consumption Type Vaccine Market Research Report 2024
Global Viral Arthritis Vaccine Market Research Report 2025
Global Combination Vaccine and Multivalent Vaccine Market Research Report 2024
Global Infant and Child Multiple Vaccine Market Research Report 2024
Global Elderly Care Products Market Research Report 2024
Human Vaccine Adjuvants Market
Global Poultry Viral Disease Vaccines Market Research Report 2024
Global Vaccination Device Market Research Report 2024
Global Pneumonia Vaccine Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions